Panel
Partnerships Leading to a Healthier Tomorrow | Future of Health Summit 2024
- North Carolina's Healthy Opportunities Pilots are projected to generate savings of approximately $80 to $85 per member per month if scaling expands from the current 20,000 participants to the full state Medicaid population of 2.8 million.
- Medicaid expansion enrollment in North Carolina, currently at 578,000 over the past 11.5 months, is expected to continue at full speed through the end of the program's timeline.
- Reverse enrollment of SNAP recipients into Medicaid is anticipated to face continued administrative barriers until rules and appropriations committees implement specific changes.
- Social determinants of health pilots leveraging civic organizations and community-based workers are predicted to build trust that expands services from food distribution to domestic violence assistance, primary care, and Medicaid eligibility.
- These social determinants pilots are also expected to evolve into a sustainable funding model for community-based organizations, transitioning from food boxes to holistic relationship building and support.
- A statistically significant reduction in emergency department visits and hospitalizations within North Carolina pilots is cited as evidence that addressing upstream drivers of health is essential for future prevention success.
- The "dawn of the golden age of medicine," characterized by technologies for prevention, control, and cure, is forecast to arrive within the third quarter of a century, contingent on the industry avoiding self-impediment.
- The US healthcare system is expected to retain its position as the global leader in life sciences innovation for many years due to the difficulty in replicating its university and hospital research infrastructure.
- Approximately 70% of new medicines originating from small emerging biotechnology companies are expected to continue driving the ecosystem's virtuous circle, provided the supply chain remains resilient and intellectual property is protected.
- Biotechnology efforts in agriculture, such as preventing apples from browning, are predicted to significantly impact school budgets and child nutrition, offering a role for biotech in addressing food insecurity.
- The US healthcare industry is expected to require a "21st-century access act" to re-imagine co-pays and out-of-pocket costs, as producing new medicines alone is deemed insufficient for public health success.
- Transparency in the pharmaceutical supply chain is expected to be necessary to de-link intermediaries like PBMs and wholesalers, who currently face a perverse disincentive where higher medicine prices increase their profits.
- The current fee-for-service model, which rewards volume rather than value, is expected to be dismantled to allow prevention to become a viable economic strategy under a fee-for-value framework.
- Organizations investing in population health strategies and prevention today are projected to become the primary market movers positioned for success when value-based care becomes the industry standard.
- The indiscriminate use of GLP-1s is attributed to a value chain that enables unhealthy choices, requiring upstream decision-makers to intervene to arrest these trends.
- Despite 20 years of data on health system efficiency, "elephants in the room" regarding upstream drivers like universal health care access are expected to remain unaddressed without the requisite political will to pivot toward value.
- Shifting the industry mindset toward proactive prevention is expected to eventually make the healthcare system more efficient regarding dollars spent, though the necessary collaboration remains nascent.